MedPath
NMPA Approval

胸腺五肽

国药准字H20054343

December 10, 2020

国药准字H20054343

Drug Information

胸腺五肽

原料药

化学药品

December 10, 2020

Company Information

Manufacturing Company

吉林省磐石经济开发区西点大街777号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

胸腺五肽 - NMPA 批准文号 | MedPath